MiR-223-3p targeting SEPT6 promotes the biological behavior of prostate cancer.
Wei Y, Yang J, Yi L, Wang Y, Dong Z, Liu Z, Ou-yang S, Wu H, Zhong Z, Yin Z, Zhou K, Gao Y, Yan B, Wang Z.
Wei Y, et al. Among authors: wu h.
Sci Rep. 2014 Dec 18;4:7546. doi: 10.1038/srep07546.
Sci Rep. 2014.
PMID: 25519054
Free PMC article.